Boston / Cambridge
Science-first branding for the world's most competitive biotech ecosystem. We build brand systems that meet the rigor Boston investors and partners expect.

Credibility
Enterprise
Academic
Scientific credibility. Enterprise partnerships. Academic spin-out storytelling that resonates with sophisticated investors.
Pitch decks that communicate scientific rigor and commercial potential to Boston's top biotech investors.
BD decks and partnership collateral designed for enterprise pharma conversations.
Web presence that establishes scientific credibility and supports investor diligence.
Conference materials that maintain brand consistency across scientific communications.
One-pagers, datasheets, and sales materials that communicate complex science clearly.
Booth designs and event collateral for BIO and major scientific conferences.
The Boston Advantage
Boston and Cambridge represent the epicenter of biotech innovation. From Kendall Square to the Seaport, the concentration of scientific talent, academic institutions, and venture capital creates unique branding challenges.
We've built brand systems for Boston biotech companies from early-stage academic spin-outs to growth-stage enterprises pursuing pharma partnerships. Our work helps translate breakthrough science into compelling commercial narratives.
From early research to commercialization, OneBrand delivers specialized design work biotech teams rely on—without juggling agencies, freelancers, or internal bottlenecks.



One-time investment, 30-day delivery
Turn your existing brand into a production-ready system with templates, visual rules, and reusable components built for scientific credibility.
Learn moreOngoing support, pause anytime
Submit requests as needs arise. Scientific posters, investor materials, partnership decks—everything stays on brand and credible.
View plansAI Brand Systems for Boston Biotech
Discover how AI-ready brand systems enable consistent execution at scientific-grade precision.
Your brand should reflect the rigor of your science. Let's build a system that communicates credibility to Boston's most sophisticated investors and partners.